2015
DOI: 10.1111/jdv.13498
|View full text |Cite
|
Sign up to set email alerts
|

Explosive generalization of nodular vasculitis – Mycobacterium marinum challenges the paradigm

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 6 publications
0
2
0
Order By: Relevance
“…The patients received Etanercept and Adalimumab [25,26]. In the majority of published cases, a combination therapy with a cDMARD and a bDMARD was present [27][28][29]. In one published case a combination of two cDMARDs and one bDMARD was described [30].…”
Section: Discussionmentioning
confidence: 99%
“…The patients received Etanercept and Adalimumab [25,26]. In the majority of published cases, a combination therapy with a cDMARD and a bDMARD was present [27][28][29]. In one published case a combination of two cDMARDs and one bDMARD was described [30].…”
Section: Discussionmentioning
confidence: 99%
“…Ziehl-Neelsen staining for acid-fast bacilli and mycobacterial culture usually result negative [64,65]. However, there is one report in which M. marinum was isolated [66]. The most striking features of EI are strongly positive tuberculin purified protein derivative (PPD) with an induration greater than 20 mm and clearance of skin lesions with anti-tuberculosis therapy, which occurs within 1-6 months (mean, 2.1 months).…”
Section: Primarily-lobular Panniculitides With Vasculitismentioning
confidence: 99%